SUBSCRIBE
SUBSCRIBE
News   Policy

UCB Group Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain

August 17, 2007 | 
1 min read
BRUSSELS, BELGIUM--(MARKET WIRE)--Aug 17, 2007 -- Marketing Authorization Application for Vimpat® - the proposed new trade name for lacosamide - to treat Diabetic Neuropathic Pain has been submitted to the European regulatory authority.
Regulatory Europe
MORE ON THIS TOPIC
Trendy halftone collage. Concept of choice, make a decision left or right, ability to think in a difficult situation, question of choosing between 2 directions. Illustration for web banner, social media banner. Vector illustration
Tariffs
Trump Delays Pharma Tariffs Yet Again
October 2, 2025
 · 
2 min read
 · 
Tristan Manalac
Difficult question concept. Big question mark or big problem to solve or finding solution, doubt or uncertainty, thinking to make decision, businessman holds up big question mark.
Drug pricing
Pfizer’s Drug Pricing Deal With Trump Raises Questions About Access
October 1, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
halftone magazine style banner, dislike, negative rating, hand thumbs down
Complete response letters
Fortress, Sentynl Fail To Secure FDA Nod in Rare Pediatric Disease
October 1, 2025
 · 
2 min read
 · 
Tristan Manalac
External view of the U.S. Capitol building
Government
US Government Shuts Down, FDA Closed for New Applications
October 1, 2025
 · 
4 min read
 · 
Annalee Armstrong